Skip to main content
. 2019 Oct 10;21(2):101–107. doi: 10.1080/15384047.2019.1671110

Figure 4.

Figure 4.

Contrast-enhanced abdominal and pelvic computed tomography (CT) scan after took imatinib for 6 months (a-c) and took sunitinib for 3 months (d-f).

(a-c) Computed tomography revealed that the mesentery and pelvic cavity tumors recurred with multiple metastases (red arrow). (d-f) Computed tomography revealed proof of the mass that had been previously discovered became larger (red arrow).